Pegsebrenatide
Pegsebrenatide (NLY01) is a long-acting GLP-1R agonist designed for Parkinson's disease research, featuring enhanced brain penetration. It inhibits A1 astrocyte activation and protects dopaminergic neurons, improving motor function in preclinical PD models, supporting both in vivo and in vitro neuroprotective studies.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
